Cargando…

The role of epoxyeicosatrienoic acids in the cardiovascular system

There is increasing evidence suggesting that epoxyeicosatrienoic acids (EETs) play an important role in cardioprotective mechanisms. These include regulating vascular tone, modulating inflammatory responses, improving cardiomyocyte function and reducing ischaemic damage, resulting in attenuation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, L, Mäki-Petäjä, K, Cheriyan, J, McEniery, C, Wilkinson, I B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500322/ https://www.ncbi.nlm.nih.gov/pubmed/25655310 http://dx.doi.org/10.1111/bcp.12603

Ejemplares similares

The Role of the Autonomic Nervous System in the Regulation of Aortic Stiffness
por: Mäki-Petäjä, Kaisa M., et al.
Publicado: (2016)

Inside epoxyeicosatrienoic acids and cardiovascular disease
por: Tacconelli, Stefania, et al.
Publicado: (2014)

Cardiovascular Phenotype of Elevated Blood Pressure Differs Markedly Between Young Males and Females: The Enigma Study
por: Nardin, Chiara, et al.
Publicado: (2018)

Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study
por: Fisk, Marie, et al.
Publicado: (2018)

The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling
por: Lai, Jinsheng, et al.
Publicado: (2021)

Evaluation of inert gas rebreathing for determination of cardiac output: influence of age, gender and body size
por: Middlemiss, Jessica E., et al.
Publicado: (2018)

Anti-Inflammatory Effects of Epoxyeicosatrienoic Acids
por: Thomson, Scott J., et al.
Publicado: (2012)

Plasma epoxyeicosatrienoic acids and diabetes-related cardiovascular disease: The cardiovascular health study
por: Lemaitre, Rozenn N., et al.
Publicado: (2022)

Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies
por: Guan, Xin-Xin, et al.
Publicado: (2021)

Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study
por: Fermont, Jilles M, et al.
Publicado: (2020)

The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial
por: Fisk, Marie, et al.
Publicado: (2018)

Mechanisms underlying elevated SBP differ with adiposity in young adults: the Enigma study
por: Middlemiss, Jessica E., et al.
Publicado: (2016)

Epoxyeicosatrienoic Acids Enhance Embryonic Haematopoiesis and Adult Marrow Engraftment
por: Li, Pulin, et al.
Publicado: (2015)

Role of Vascular Adaptation in Determining Systolic Blood Pressure in Young Adults
por: Yu, Shikai, et al.
Publicado: (2020)

Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial
por: McEniery, Carmel M., et al.
Publicado: (2020)

Aging, Estrogen Loss and Epoxyeicosatrienoic Acids (EETs)
por: Lee, Alison R., et al.
Publicado: (2013)

Novel Mechanism for Buffering Dietary Salt in Humans: Effects of Salt Loading on Skin Sodium, Vascular Endothelial Growth Factor C, and Blood Pressure
por: Selvarajah, Viknesh, et al.
Publicado: (2017)

ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial
por: McEniery, Carmel M., et al.
Publicado: (2020)

Quantitative (18)F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD
por: Vass, Laurence, et al.
Publicado: (2021)

Placental syndromes and maternal cardiovascular health
por: Casey, Helen, et al.
Publicado: (2023)

Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial
por: Gajendragadkar, Parag R., et al.
Publicado: (2014)

Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study
por: Cacciottolo, Paul J, et al.
Publicado: (2021)

Skin Sodium and Hypertension: a Paradigm Shift?
por: Selvarajah, Viknesh, et al.
Publicado: (2018)

CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators
por: Shi, Zeqi, et al.
Publicado: (2022)

Development of Epoxyeicosatrienoic Acid Analogs with in Vivo Anti-Hypertensive Actions
por: Imig, John D., et al.
Publicado: (2010)

Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
por: Hye Khan, Md. Abdul, et al.
Publicado: (2014)

Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response
por: Samokhvalov, V, et al.
Publicado: (2013)

Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients
por: Duflot, Thomas, et al.
Publicado: (2021)

Biomarkers of cardiovascular risk across phenotypes of osteoarthritis
por: Provan, S. A., et al.
Publicado: (2019)

The arachidonic acid metabolite 11,12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis
por: Kim, Hak Su, et al.
Publicado: (2021)

11,12 Epoxyeicosatrienoic Acid Rescues Deteriorated Wound Healing in Diabetes
por: Sommer, Katharina, et al.
Publicado: (2021)

Sexually dimorphic adaptation of cardiac function: roles of epoxyeicosatrienoic acid and peroxisome proliferator‐activated receptors
por: Qin, Jun, et al.
Publicado: (2016)

Plasma epoxyeicosatrienoic acids and dihydroxyeicosatrieonic acids, insulin, glucose and risk of diabetes: The strong heart study
por: Lemaitre, Rozenn N., et al.
Publicado: (2021)

Effects of angiotensin II receptor blockers on serum levels of epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids in patients admitted to a cardiovascular center
por: Kato, Yuka, et al.
Publicado: (2021)

Maternal Cardiovascular Dysfunction is Associated with Hypoxic Cerebral and Umbilical Doppler Changes
por: Masini, Giulia, et al.
Publicado: (2020)

Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
por: Skibba, Melissa, et al.
Publicado: (2017)

Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
por: Pavey, Holly, et al.
Publicado: (2023)

Stiffening and ventricular–arterial interaction in the ascending aorta using MRI: ageing effects in healthy humans
por: Li, Ye, et al.
Publicado: (2019)

Fatty acid binding proteins are novel modulators of synaptic epoxyeicosatrienoic acid signaling in the brain
por: Glaser, Sherrye T., et al.
Publicado: (2023)

Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease
por: Fisk, Marie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uuesul69l6avptf3i3h8358oqk